FDA white paper encourages adoption of selective safety data collection
Regulatory NewsJoanne S. Eglovitch
CDERClinical TrialsPatient engagementPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyTechnical documentationUnited StatesUS Food and Drug Administration (FDA)